Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Hypophosphatemic rickets: results of a long-term follow-up (2006)

  • Authors:
  • USP affiliated authors: KOCH, VERA HERMINIA KALIKA - FM
  • USP Schools: FM
  • DOI: 10.1007/s00467-005-2077-4
  • Subjects: SEGUIMENTOS; OSSO E OSSOS (METABOLISMO); CÁLCIO (DEFICIÊNCIA); ACIDOSE; VITAMINA D (DEFICIÊNCIA); POTÁSSIO; FOSFATOS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00467-005-2077-4 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM10700091248-SFM BCSEP 101 2006
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      VAISBICH, Maria Helena; KOCH, Vera H. Hypophosphatemic rickets: results of a long-term follow-up. Pediatric Nephrology, New York, v. 21, n. 2, p. 230-234, 2006. Disponível em: < http://www.springerlink.com/content/u381033504127642/fulltext.pdf > DOI: 10.1007/s00467-005-2077-4.
    • APA

      Vaisbich, M. H., & Koch, V. H. (2006). Hypophosphatemic rickets: results of a long-term follow-up. Pediatric Nephrology, 21( 2), 230-234. doi:10.1007/s00467-005-2077-4
    • NLM

      Vaisbich MH, Koch VH. Hypophosphatemic rickets: results of a long-term follow-up [Internet]. Pediatric Nephrology. 2006 ; 21( 2): 230-234.Available from: http://www.springerlink.com/content/u381033504127642/fulltext.pdf
    • Vancouver

      Vaisbich MH, Koch VH. Hypophosphatemic rickets: results of a long-term follow-up [Internet]. Pediatric Nephrology. 2006 ; 21( 2): 230-234.Available from: http://www.springerlink.com/content/u381033504127642/fulltext.pdf

    Referências citadas na obra
    Tenehouse HS, Murer H (2003) Disorders of renal tubular phosphate transport. J Am Soc Nephrol 14:240–247
    Kronenberg HM (2002) NPT2a—The key to phosphate homeostasis. N Eng J Med 347:1022–1024
    Takeda E, Yamamoto H, Nashiki K, Sato T, Arai H, Taketani Y (2004) Inorganic phosphate homeostasis and the role of dietary phosphorus. J Cell Mol Med 8:191–201
    Nenet-Pages A, Lorenz-Depiereux B, Zischka H, White KE, Econs MJ, Strom TM (2004) FGF-23 is processed by proprotein convertase but not by PHEX. Bone 35:455–462
    Liu S, Guo R, Simpson LG, Kiao ZS, Burnham CE, Quarles LD (2003) Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278(39):37419–37426
    White KE, Carn GC, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079–2086
    Bowe AE, Finnegan R, Beur SMJ, Cho J, Levine MA, Kumar R, Schiavi SC (2001) FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun 284:977–981
    Quarles LD (2003) FGF-23, PHEX and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285:E1–E9
    Kruse A, Dracht U, Gopfert G (1982) Renal threshold phosphate concentration (TmPO4/GFR) Arch Dis Child 57:217–223
    Brodehl J, Krause A, Hoyer P (1988) Assessment of maximal tubular phosphate reabsorption: Comparison of direct measurement with the nomogram of Bijvoet. Pediatr Nephrol 2:183–189
    Patriquin H, Robitaille P (1986) Renal calcium deposition in children: sonographic demonstration of the Anderson-Carr progression. AJR Am J Roentgenol 146:1253–1256
    Kooh SW, Binet A, Daneman A (1994) Nephrocalcinosis in X-linked hypophosphatemic rickets: its relationship to treatment, kidney function, and growth. Clin Invest Med 17:123–130
    Friedman NE, Lobaugh B, Drezner MK (1993) Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 76:839–844
    Doria A, Kooh SW, Cole WG, Daneman A, Sochett E (2003) Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88:3591–3597
    Patzer L, van’t Hoff W, Shah V, Hallson P, Kasidas GP, Samuell C, de Bruyn R, Barrat TM, Dillon MJ (1999) Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren. J Pediatr 135:611–617
    Reusz GS, Latta K, Hoyer PF, Byrd DJ, Ehrich JH, Brodehl J (1990) Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated rickets. Lancet 335:1240–1243
    Schonaue E, Kruse K, Bohles HJ, Sewell AC (1992) More evidence for hyperoxaluria in phosphate-treated X-linked familial hypophosphatemic rickets. Eur J Pediatr 151:390
    Reusz GS, Hoyer PF, Lucas M, Krohn HP, Ehrich JHH, Brodehl J (1990) X-Linked hypophosphatemic: treatment, height gain, and nephrocalcinosis. Arch Dis Child 65:1125–1128
    Alon U, Donaldson DL, Hellerstein S, Warady BA, Harris DJ (1992) Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse. J Pediatr 120:899–905
    Goodyer PR, Kronick JB, Jequier S, Reade TM, Scriver CR (1987) Nephrocalcinosis and its relationship to treatment of hereditary rickets. J Pediatr 111:700–704
    Verge CF, Lam A, Simpson JM, Cowell CT, Hoeard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Eng J Med 325:1843–1848
    Seikaly M, Browne R, Baum M (1996) Nephrocalcinosis is associated with renal tubular acidosis in children with X-linked hypophosphatemia. Pediatrics 97:91–93
    Minari M, Castellani A, Garella S (1984) Renal tubular acidosis associated with vitamin D-resistant rickets. Miner Electrolyte Metab 10:371–374
    Saggese G, Baroncelli GI, Bertelloni S, Perri G (1995) Long-term growth hormone treatment in children with renal hypophosphatemic rickets: Effects on growth, mineral metabolism, and bone density. J Pediatr 127:395–402
    Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G (2001) Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets. J Pediatr 138:236–243
    Reusz GS, Miltenyi G, Stubnya G, Szabo A, Horvath C, Byrd DJ, Peter F, Tulassay T (1997) X-linked hyperphosphatemia: effects of treatment with recombinant human growth hormone. Pediatr Nephrol 11:573–577
    Haffner D, Wuhl E, Blum WF, Schaefer F, Mehls O (1995) Disproportionate growth following long-term growth hormone treatment in short children with X-linked hypophosphatemia. Eur J Pediatr 154:610–613
    Nissel R, Wuhl E, Mehls O (2004) Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets. Pediatrics 113:e593–596
    Scott A, Rivkees AS, El-Hajj-Fuleihan G, Brown EM, Crawford JD (1992) Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab 75:1514–1518
    Gosnell JE, Posen S, Reeve TS, Delbridge LW (2004) Parathyroidectomy for tertiary hyperparathyroidism associated with X-linked dominant hypophosphatemic rickets. Arch Surg 139:218–222